Literature DB >> 30167571

CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy.

Jeffrey Daniel Jenks1, Martin Hoenigl2,3,4.   

Abstract

Entities:  

Year:  2018        PMID: 30167571      PMCID: PMC6112816          DOI: 10.21037/jlpm.2018.01.10

Source DB:  PubMed          Journal:  J Lab Precis Med        ISSN: 2519-9005


× No keyword cloud information.
  7 in total

1.  Intensification of a suppressive HAART regimen increases CD4 counts and decreases CD8+ T-cell activation.

Authors:  Michael A Kolber; María O Saenz; Tom J Tanner; Kristopher L Arheart; Savita Pahwa; Huanliang Liu
Journal:  Clin Immunol       Date:  2007-11-09       Impact factor: 3.969

2.  CD4/CD8 Cell Ratio in Acute HIV Infection and the Impact of Early Antiretroviral Therapy.

Authors:  Martin Hoenigl; Antoine Chaillon; Susan J Little
Journal:  Clin Infect Dis       Date:  2016-05-03       Impact factor: 9.079

3.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

4.  A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

Authors:  Christine Danel; Raoul Moh; Delphine Gabillard; Anani Badje; Jérôme Le Carrou; Timothée Ouassa; Eric Ouattara; Amani Anzian; Jean-Baptiste Ntakpé; Albert Minga; Gérard M Kouame; Franck Bouhoussou; Arlette Emieme; Antoine Kouamé; André Inwoley; Thomas-d'Aquin Toni; Hugues Ahiboh; Mathieu Kabran; Cyprien Rabe; Baba Sidibé; Gustave Nzunetu; Romuald Konan; Joachim Gnokoro; Patrice Gouesse; Eugène Messou; Lambert Dohoun; Synali Kamagate; Abo Yao; Solange Amon; Amadou-Barenson Kouame; Aboli Koua; Emmanuel Kouamé; Yao Ndri; Olivier Ba-Gomis; Marcelle Daligou; Simplice Ackoundzé; Denise Hawerlander; Alex Ani; Fassery Dembélé; Fatoumata Koné; Calixte Guéhi; Constance Kanga; Serge Koule; Jonas Séri; Mykayila Oyebi; Nathalie Mbakop; Olewole Makaila; Carole Babatunde; Nathanael Babatounde; Gisèle Bleoué; Mireille Tchoutedjem; Alain-Claude Kouadio; Ghislaine Sena; Sahinou-Yediga Yededji; Rodrigue Assi; Alima Bakayoko; Alassane Mahassadi; Alain Attia; Armel Oussou; Max Mobio; Doféré Bamba; Mesmin Koman; Apollinaire Horo; Nina Deschamps; Henri Chenal; Madeleine Sassan-Morokro; Seidou Konate; Kakou Aka; Eba Aoussi; Valérie Journot; Célestin Nchot; Sophie Karcher; Marie-Laure Chaix; Christine Rouzioux; Papa-Salif Sow; Christian Perronne; Pierre-Marie Girard; Hervé Menan; Emmanuel Bissagnene; Auguste Kadio; Virginie Ettiegne-Traore; Corinne Moh-Semdé; Abo Kouame; Jean-Marie Massumbuko; Geneviève Chêne; Mireille Dosso; Serge K Domoua; Thérèse N'Dri-Yoman; Roger Salamon; Serge P Eholié; Xavier Anglaret
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

5.  The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age.

Authors:  Anders Wikby; Ingrid A Månsson; Boo Johansson; Jan Strindhall; Sven E Nilsson
Journal:  Biogerontology       Date:  2008-03-28       Impact factor: 4.277

6.  Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study.

Authors:  J B Margolick; A Muñoz; A D Donnenberg; L P Park; N Galai; J V Giorgi; M R O'Gorman; J Ferbas
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

7.  CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).

Authors:  Adam Trickey; Margaret T May; Philipp Schommers; Jan Tate; Suzanne M Ingle; Jodie L Guest; M John Gill; Robert Zangerle; Mike Saag; Peter Reiss; Antonella d'Arminio Monforte; Margaret Johnson; Viviane D Lima; Tim R Sterling; Matthias Cavassini; Linda Wittkop; Dominique Costagliola; Jonathan A C Sterne
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079

  7 in total
  1 in total

1.  DOLAMA study: Effectiveness, safety and pharmacoeconomic analysis of dual therapy with dolutegravir and lamivudine in virologically suppressed HIV-1 patients.

Authors:  Carmen Hidalgo-Tenorio; Luis López Cortés; Alicia Gutiérrez; Jesús Santos; Mohamed Omar; Carmen Gálvez; Sergio Sequera; Samantha Eisabeth De Jesús; Franciso Téllez; Elisa Fernández; Coral García; Juan Pasquau
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.